To be the most valuable and preferred innovative API manufacturer and CDMO partner.
Contribute to healthcare by supporting the improvement of medicine's availability and affordability.
Current Position: Home > About Langhua > One -Stop Solution for Full Lifecycle
The Integrated Viva-Langhua drug development efforts provide a 'Real'
One-Stop solutions to the entire development lifecycle
from discovery to commercial supply.
About Viva Biotech
Viva Biotech (01873.HK), is the parent company of langhua pharma. Since its establishment in 2008, Viva Biotech (01873.HK) has always been adhering to the mission of "Becoming the cradle of global innovative biotech companies from around the world" and provided one-stop services for drug R&D and production to global biopharmaceutical innovators. Leveraging the technical advantages in the field of Structure-based Drug Discovery (SBDD), Viva Biotech provides leading CRO drug discovery services and CMC / CDMO services throughout the whole drug production process to global biopharmaceutical clients. At the same time, Viva Biotech focus on finding and investing in high potential biotech start-ups, solve unmet clinical medical needs in the form of EFS (service for equity), and continue to build an open cooperation platform and win-win ecosystem for biotech innovation.
As of June 30, 2021, Viva Biotech has provided drug R&D and production services to 1,695 biotech and pharmaceutical clients around the world, and have invested and incubated 75 biotech start-ups in total.
